Anna Ioannidou, Ph.D.

Preclinical Researcher

Dr. Anna Ioannidou has a background in biological research, including a combination of in vivo and in vitro work, ranging from basic molecular biology to physiology/metabolic studies. Dr. Ioannidou is interested in understanding complex diseases and contributing to the development of therapeutic interventions, aiming to eliminate life-threatening conditions and improve patients’  life quality.

Dr. Ioannidou obtained her Biology degree in the design and development of monoclonal antibodies and continued by pursuing her Master’s studies in Molecular Biology-Biomedicine. Subsequently, during her doctoral studies, her research focus expanded to in vivo work and focused on the interplay between genomic instability and immunometabolism. After obtaining her Ph.D. in 2020, Dr. Ioannidou joined Assist. Prof. Carolina Hagberg’s group as a Postdoctoral fellow at Karolinska Institutet, where she focused on the role of the vascular endothelium in the development of obesity and metabolic abnormalities.


2020, Ph.D., Biology Department, University of Crete, Heraklion, Greece

2014, M.Sc. in Molecular Biology-Biomedicine
Biology Department, University of Crete, Heraklion, Greece 

2012, B.Sc. in Biology
Biology Department, University of Crete, Heraklion, Greece